Edogawa-ku, Japan

Atsunobu Sakamoto

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.3

ph-index = 1


Location History:

  • Tokyo, JP (2015)
  • Edogawa-ku, JP (2019 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Atsunobu Sakamoto

Introduction

Atsunobu Sakamoto is a notable inventor based in Edogawa-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of eye diseases. With a total of 3 patents to his name, Sakamoto's work is recognized for its innovative approach to addressing complex medical challenges.

Latest Patents

Sakamoto's latest patents focus on a sustained-release pharmaceutical composition designed for the treatment and prevention of eye diseases. His inventions involve a terpenoid derivative that activates the Keap1/Nrf2/ARE signaling pathway, showcasing excellent anti-inflammatory and cytoprotective actions. The sustained-release composition is effective for treating posterior eye diseases caused by oxidative stress. It is designed to maintain pharmacological action for one week or longer, ensuring a prolonged therapeutic effect. This innovative approach includes a base material that is administrable to the vitreous body, enhancing the delivery and efficacy of the treatment.

Career Highlights

Atsunobu Sakamoto is affiliated with Daiichi Sankyo Company, Limited, where he continues to develop groundbreaking pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of eye diseases, contributing to the overall improvement of patient care in this area.

Collaborations

Sakamoto has collaborated with esteemed colleagues such as Yuji Kasuya and Yasuhiro Nakagami. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their research.

Conclusion

Atsunobu Sakamoto's contributions to the field of pharmaceuticals, particularly in eye disease treatment, highlight his role as a leading inventor. His innovative patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…